Status:
COMPLETED
Exosomes Implication in PD1-PD-L1 Activation in OSAS
Lead Sponsor:
University Hospital, Angers
Conditions:
Sleep Apnea Syndromes, Obstructive
Cancer
Eligibility:
All Genders
18+ years
Brief Summary
An increased occurrence of cancer associated mortality has been described in patients with Obstructive Sleep Apnea Syndrome (OSAS). This association might be partially explained by an impaired cellula...
Eligibility Criteria
Inclusion
- Patients requiring a sleep recording for suspected OSAS
Exclusion
- Préviously treated OSAS
- Cancer past history
- Pregnant women
- Cognitif impairment
Key Trial Info
Start Date :
March 3 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 14 2020
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT03811600
Start Date
March 3 2019
End Date
October 14 2020
Last Update
February 10 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Laboratoire du Sommeil, Département de Pneumologie, CHU d'Angers
Angers, France, 49100